Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Yasunori Megumi"'
Autor:
Akira Kawai, Hiroyuki Narahara, Shunji Takahashi, Tomoki Nakamura, Hiroshi Kobayashi, Yasunori Megumi, Toshiyuki Matsuoka, Eisuke Kobayashi
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background Soft tissue sarcomas (STSs) are a heterogeneous group of cancers with over 100 described subtypes. While these cancers are infrequent, the prognosis is quite poor, particularly for those with stage IV metastatic disease. Patients
Externí odkaz:
https://doaj.org/article/3a223146706049508eaffc04a1002708
Autor:
Akira Kawai, Hiroyuki Narahara, Shunji Takahashi, Tomoki Nakamura, Hiroshi Kobayashi, Yasunori Megumi, Toshiyuki Matsuoka, Eisuke Kobayashi
Publikováno v:
BMC cancer. 22(1)
Background Soft tissue sarcomas (STSs) are a heterogeneous group of cancers with over 100 described subtypes. While these cancers are infrequent, the prognosis is quite poor, particularly for those with stage IV metastatic disease. Patients for whom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99303938b53e420acc17a8c6e32ee652
https://pubmed.ncbi.nlm.nih.gov/35546669
https://pubmed.ncbi.nlm.nih.gov/35546669
Autor:
Eisuke Kobayashi, Makoto Endo, Aiko Maejima, Yoichi Naito, Yasunori Megumi, Shunji Takahashi, Akira Kawai, Naofumi Asano
Publikováno v:
Japanese Journal of Clinical Oncology
Interim analysis from the first large-scale post-marketing surveillance study of eribulin treatment for soft tissue sarcomas (STSs) showed antitumor activity in both common and rare subtypes of STS (NCT03058406).
Background Although eribulin is
Background Although eribulin is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae8e2572b073b17a62e1baba144e27d3
https://doi.org/10.1093/jjco/hyz096
https://doi.org/10.1093/jjco/hyz096